February 03, 2000 07:50
ProxyMed, Inc. Announces Agreement With North American Medical Management of California
- ProxyMed eSolutions to Benefit 8,000 California Physicians -
FT LAUDERDALE, Fla., Feb. 3 /PRNewswire/ -- ProxyMed, Inc. (Nasdaq: PILL), a leading provider of eHealth physician solutions and business-to-business healthcare transaction services, and North American Medical Management of California (NAMM), a wholly owned subsidiary of PhyCor (Nasdaq: PHYC), which specializes in the management of independent physician associations (IPAs) have signed an agreement for ProxyMed to deliver eHealth transaction services to NAMM physicians including the electronic processing of claims and encounters and other transaction services. The agreement includes Optical Character Recognition (OCR) scanning of paper claims and encounters, editing of data for validation and integrity, and routing data to the NAMM processing system.
"This is a great opportunity for NAMM to achieve it's aggressive EDI goals by capitalizing on ProxyMed's experience in the Western US where we have 2,000 NAMM physicians who are directly connected to ProxyMed while providing us with the opportunity to reach an additional 6 ,000 NAMM physicians" said John Okkerse, PhD., Chief Executive Officer of ProxyMed, Inc.
"We chose ProxyMed because they were able to offer us a wide array of EDI services that fit our specific needs today as well as the needs of our physicians." said Chuck Wunderlich, Director of Technology Development, NAMM. "We had an immediate need to implement one of our new services and ProxyMed was able to deliver the solution into the new system we recently implemented. This new scanning service will save us considerable time and money."
Mr. Wunderlich added, "A lot of our physicians and specialists are already connected to the ProxyNet network. This makes it easy for us to enter claims and encounters electronically allowing us to eliminate receiving this data on paper, and making us an overall more efficient company."
ProxyMed, Inc. is one of the nation's largest and most experienced eHealth companies providing eSolutions to physicians and business to business healthcare electronic commerce services to healthcare information systems providers. Through ProxyMed's desktop software and proxyMed.com physicians will be able to securely exchange clinical and financial messages with payors, labs, pharmacies, suppliers, and their patients. ProxyMed's e-commerce solutions simplify the financial, administrative and clinical processes of the physician's office resulting in more cost effective healthcare management and increased quality of patient care.
North American Medical Management (NAMM) develops and manages Independent Practice Associations (IPA's), providing medical management and related support services to assist physicians in their managed care operations. NAMM currently administers a California enrollment of over 350,000 managed care members with 30 IPA's representing approximately 8,000 physicians and specialists statewide. PhyCor, Inc., headquartered in Nashville, Tennessee, is a medical network management company that operates multi-specialty groups, manages independent practice associations (IPA), and provides health care decision support services to consumers.
Note: This News Release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include assumptions, beliefs and opinions relating to ProxyMed's growth strategy based upon ProxyMed's interpretation and analysis of healthcare industry trends, and management's ability to successfully develop, implement, market and sell its network transaction processing services, software programs, clinical and financial transaction services, and e-commerce systems to physicians and other healthcare providers. This strategy assumes that ProxyMed will be able to successfully develop and execute its strategic relationships, especially with the providers of healthcare information systems, with pharmacy chains and independent pharmacy owners, and with clinical medical laboratories. Many known and unknown risks, uncertainties and other factors, including general economic conditions and risk factors detailed from time to time in ProxyMed's Securities and Exchange Commission filings, may cause these forward-looking statements to be incorrect and may cause actual results to be materially different from any future results expressed or implied by these assumptions, opinions and beliefs. ProxyMed expressly disclaims any intent or obligation to update any forward-looking statements.
More information on ProxyMed is available on its home page at proxymed.com.
SOURCE ProxyMed, Inc. |
